Kymera Therapeutics (KYMR) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Kymera Therapeutics (KYMR) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 29.47% |
| 10 | Kymera Therapeutics | 10.92 Bn | 10.26 Bn | - | 32.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.80% |
| Sep 30, 2025 | 25.82% |
| Jun 30, 2025 | 11.74% |
| Mar 31, 2025 | -29.53% |
| Dec 31, 2024 | -117.19% |
| Sep 30, 2024 | -59.79% |
| Jun 30, 2024 | -92.32% |
| Mar 31, 2024 | -77.02% |
| Dec 31, 2023 | 93.69% |
| Sep 30, 2023 | -100.15% |
| Jun 30, 2023 | 91.48% |
| Mar 31, 2023 | 87.31% |
| Dec 31, 2022 | -21.38% |
| Sep 30, 2022 | 93.26% |